CIK: 0001917529 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 6, 2025
Total Value ($000): $819,652 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 4,896,462 | $196,985 | 24.0% | $58.25 | -22.5% | Common Stock | 501575104 |
| DYN | Dyne Therapeutics, Inc. | 8,019,354 | $188,936 | 23.1% | $13.82 | +114.0% | Common Stock | 26818M108 |
| IRON | Disc Medicine, Inc. | 2,509,456 | $159,100 | 19.4% | $48.39 | +19.5% | Common Stock | 254604101 |
| — | Third Harmonic Bio, Inc. | 10,402,286 | $107,040 | 13.1% | $18.97 | — | Common Stock | 88427A107 |
| DAWN | Day One Biopharmaceuticals, Inc. | 6,430,257 | $81,471 | 9.9% | $19.68 | -29.3% | Common Stock | 23954D109 |
| KRRO | Korro Bio, Inc. | 1,137,149 | $43,291 | 5.3% | $33.30 | +54.3% | Common Stock | 500946108 |
| — | Vigil Neuroscience, Inc. | 5,836,874 | $9,923 | 1.2% | $7.03 | — | Common Stock | 92673K108 |
| — | Generation Bio, Co. | 8,279,484 | $8,776 | 1.1% | $7.08 | — | Common Stock | 37148K100 |
| — | Ikena Oncology, Inc. | 5,018,178 | $8,230 | 1.0% | $12.54 | — | Common Stock | 45175G108 |
| QTTB | Q32 Bio, Inc. | 2,092,106 | $7,197 | 0.9% | $13.78 | +129.2% | Common Stock | 746964105 |
| — | Aerovate Therapeutics, Inc. | 1,799,232 | $4,768 | 0.6% | $11.88 | — | Common Stock | 008064107 |
| TECX | Tectonic Therapeutics, Inc. | 78,447 | $3,622 | 0.4% | $15.77 | +168.1% | Common Stock | 878972108 |
| SPRO | Spero Therapeutics, Inc. | 305,255 | $314 | 0.0% | $15.88 | -92.5% | Common Stock | 84833T103 |